Grail Company
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Investors
Technology:
Сancer Diagnostics
Industry:
Omic
Headquarters:
Menlo Park, California, United States
Founded Date:
2016-01-01
Employees Number:
501-1000
Funding Status:
M&A
Investors Number:
23
Total Funding:
$2,004,655,040.00
Estimated Revenue:
$100M to $500M
Last Funding Date:
2020-05-06
Last Funding Type:
Series D
Register and Claim Ownership